Polarean Imaging Share Discussion Threads

[volsung] 22/4/2021 09:06

Go Polarean

[markstevenkirby80] 22/4/2021 09:06

Be a 100p blink of an eye

[rhatton] 20/4/2021 18:14

A takeout by bracco could be a few years off but no doubt are in the mix with the set up as you say.

Blue earth diagnostics had revenues of around $140 million in 2019 when the acquisition by bracco completed

[moontheloon] 20/4/2021 17:39

Think bracco could swoop for full takeover after fda approval, otherwise they wouldn't have built a stake and a position on the board (which I believe they have) just hope pis don't get shafted on price

[mcfly79] 20/4/2021 15:23

Just listened to the Q&A from the InvestorMeetCompany presentation.


Richard states that there are 11,000 hospitals in the US. He states they will target the top 100 hospitals affiliated with academic institutes in the first few years, and they would see their polarisers in all hospitals over the course of the next 10 years!

[mcfly79] 20/4/2021 10:47

A case can be made for a high value buy out by a large imaging company like Bracco, or a large medical equipment manufacturer.

If Polarean’s technology becomes the de facto standard in pulmonary imaging then it could eventually have well over 1,000 units installed in the US alone.

[mcfly79] 20/4/2021 10:17

SP Angel gave some figures in their March 2020 research note.


They show utilisation building up to 6 scan per unit per day, over the next few years. They were assuming 1,560 scans per year per unit.


They are initially targeting high end academic institution with a goal of 100 units in the next 4 years. Sales will ramp up each year and when they reach 100 initial units it would generate $42m in annual revenue (at $270 per scan) and $26m in gross profit (at $170 per scan – c.63% gross margin).


The units themselves would also generate substantial revenue and gross profit on top of this. c.$50m in revenue and $30m in gross profit in total.


The real long term gain is when the technology filters down from the high end institutions to normal hospitals. There are more than 10,000 MRI machines in the US alone. I expect Polarean to be bought out before this though.

[rhatton] 20/4/2021 09:15

I wish I had asked in the Q&A about how many doses they envisage during one day of operation at one hospital.

Would give a good idea of profitability.
We know it’s roughly $170 Gross per xenon bag. I wonder how many would be possibly per day in one hospital.

[rhatton] 19/4/2021 19:34

One deviation slightly from what they have said in previous RNS and referenced on one of Justin waites videos, regarding targeting the top 1000 institutions, looks like it will be the top 100 initially over 48 months. Seems much more manageable than 1000

[loglorry1] 19/4/2021 17:23

I don't know why they don't go onto NASDAQ. I know its expensive but they just raised a lot more than they said they were going to.

Makes no sense to me but WTFDIK.

[supernumerary] 19/4/2021 16:44

rHatton - thanks, not much further information, but always nice to see they're trying to respond properly to investor questions.

Four? times they rejected the idea of a Nasdaq listing. Probably means it's in the early planning stage :¬)

[rhatton] 19/4/2021 16:19

Q&A released on the investor presentation from a couple of weeks back.
Some good bits in there

[loglorry1] 12/4/2021 14:05

I wrote this on 9th April

Large volume yesterday has cleared placing overhang. Should tick up now considerably.

I bought 30% more.

Clearly float is now tight and its moving back up. Huge potential.

[moontheloon] 12/4/2021 10:49

Yeah going nicely glad everything across into sipp first thing. Shame I have to wait for government top up as that's due into polx too. If not moved up a crazy amount by then. Think it will be up steady over next few months, who knows other positives might emerge before fda

[74tom] 12/4/2021 10:33

Unsurprised to see the move up this morning, last weeks presentation really was superb. Re. demonstrating demand, they already have to a large extent as they've got 20+ machines installed at some of the world's leading medical centres, FDA approval will only serve to supercharge new orders IMO.

This is where POLX have a major headstart on 4d Medical. 4d have FDA approval, but they do not have the breadth of relationships that we have, hence I expect the valuation gap to close between now and the PDUFA date. 4DX are currently at £285m cap vs our £147m, so plenty of headroom for growth :)

[markstevenkirby80] 12/4/2021 07:25

Take your pick

[moontheloon] 12/4/2021 07:20

Up or down today? Got a transfer to do

[rhatton] 10/4/2021 14:22

I think hopefully all being well approval lands late September / early October without hiccups, then they will gain some sales traction late this year early to middle next year and once they’ve demonstrated demand, either there will be buy out or they will go with a Nasdaq listing to fund further growth

[w t tutte] 10/4/2021 13:49

74. Nice to see you here as well. For me TWD needs to put a few runs on the board they made a huge misjudgment in how they handled that placement. Hopefully they have learned a lesson.

NASDAQ would be lovely here, there are so many companies there with only a fraction of what we have going for us with valuations well in excess of US$ 1 billion. Look at Nano x as an example almost US$2 billion. Or if you look over in Australia a company like EMVision, which has potentially a great new imaging product but a huge amount of wood to chop has a valuation very similar to ours and we are only month from FDA approval and commercialisation.

[74tom] 09/4/2021 12:10

Nice posts W T Tutte, haven't posted on the same board as you since the debacle over at TWD, now THAT was a messed up placing! Providing FDA approval is achieved, I'll be surprised if Bracco don't attempt to buy POLX in the next few years before they get too big. I don't think it'll be on the cheap at all and from current levels we'll all do very well.

So much of the hard work has been done now, it truly feels like a steal at £140m cap. Will POLX ever list on NASDAQ? Richard did seem to hint at this in the presentation & it would undoubtedly boost the price... presumably timing wise this would be post FDA approval to raise growth capital?

[loglorry1] 09/4/2021 11:42

I think the FDA have given a date of early October so it's unlikely to be before then. It's possible but unlikely.

[moontheloon] 09/4/2021 11:21

And October at the very latest it could be a month away... Any time really till October

[moontheloon] 09/4/2021 11:20

It's not out of question seeing some more deals for a machine in the meantime

[loglorry1] 09/4/2021 11:14

I think it is pretty tightly held outside of a few private investors and I think Justin will be instrumental in keeping the story alive until October.